CAS 151213-40-0
:(4aS,7aS)-Octahidro-1H-pirrolo[3,4-b]piridina
Fórmula:C7H14N2
InChI:InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2/t6-,7+/m0/s1
Chave InChI:InChIKey=KSCPLKVBWDOSAI-NKWVEPMBSA-N
SMILES:[C@]12([C@@](CNC1)(NCCC2)[H])[H]
Sinónimos:- (1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
- (1S,6S)-cis-2,8-Diazabicyclo[4.3.0]nonane
- (4AS,7aS)-Octahydro-1H-pyrrole[3,4-b]pyridine
- (4aS,7aS)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride
- (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
- (S,S)-2,8-Diazabicyclo[4,3,0]Nonane
- (S,S)-2,8-Diazabicyclo[4,3,0]Onoane
- (S,S)-2,8-Diazabicylco(4,3,0)Nonane
- 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-
- 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS-cis)-
- Cis-Octahydropyrrolo[3,4-B]Pyridine
- Moxifloxacin side chain
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 10 produtos.
(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:Fórmula:C7H14N2Pureza:>98.0%(GC)Cor e Forma:Colorless to Light orange to Yellow clear liquidPeso molecular:126.20(S,S)-2,8-Diazabicyclo [4,3,0]nonane
CAS:Fórmula:C7H14N2Pureza:97%Cor e Forma:LiquidPeso molecular:126.1995(1S,6S)-2,8-Diazabicyclo[4.3.0]Nonane
CAS:(1S,6S)-2,8-Diazabicyclo[4.3.0]NonaneFórmula:C7H14N2Pureza:98%Peso molecular:126.2(S,S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridineFórmula:C7H14N2Pureza:97%Peso molecular:126.21H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-
CAS:Pureza:97%Cor e Forma:LiquidPeso molecular:126.2(S,S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:Produto ControladoApplications Moxifloxacin intermediate
Fórmula:C7H14N2Cor e Forma:NeatPeso molecular:126.2(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
CAS:(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane is a chiral compound that can be made from the reaction of an organic acid with an amino alcohol. The enantiomers of this compound have shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. The synthetic process for this compound was originally developed in the 1980s by researchers at the University of Illinois. They were able to show that it was possible to make a carbonyl reduction product using imidodicarbonic acid and an organic solvent. This led to the synthesis of moxifloxacin hydrochloride, which is used as a treatment for bacterial infections such as tuberculosis or pneumonia.Fórmula:C7H14N2Pureza:Min. 95%Cor e Forma:Colourless To Brown LiquidPeso molecular:126.2 g/molRef: 3D-FD14784
Produto descontinuado









